ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1182

Fluorescence Optical Imaging in the Diagnosis of Individuals Suspected of Arthritis Development – a Probabilistic Approach

Yogan Kisten1, Adrian Levitsky 1, Hamed Rezaei 1, Aase Hensvold 2, Per Larsson 3, Erik af Klint 1, Ronald van Vollenhoven 4 and Anca Catrina 5, 1Rheumatology unit Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 2Rheumatology unit Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Stockholm, 3Center for Rheumatology, Academic Specialist Center, Stockholm Health Services, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 4Amsterdam Rheumatology and immunology Center, Netherlands., Amsterdam, Netherlands, 5Rheumatology unit Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: biomarkers and anti-citrullinated protein/peptide antibodies (ACPA), Diagnostic imaging, Doppler ultrasound, Early Rheumatoid Arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Imaging Of Rheumatic Diseases Poster II

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Among the arsenal of available techniques for arthritis prediction and diagnosis, fluorescence optical imaging (FOI) has shown to be useful in detecting clinically manifest and silent synovitis of the hands of patients with various rheumatic diseases. Using a probabilistic approach, we now assess the diagnostic utility of FOI in individuals that are at increased risk of inflammatory arthritis (RA in particular).

Methods: Those suspected of inflammatory arthritis were referred to the rheumatology unit and clinic of the Karolinska University Hospital. On acquiring informed consent and medical history, the standard clinical examination coupled with ultrasound findings of the hands and feet were assessed. Laboratory results included ESR, CRP, RF and ACPA tests. Using the above information, a diagnostic probability assessment was completed by the responsible rheumatologist, where the probability of a) any inflammatory joint disease and b) Rheumatoid/RA was given on a 5 point scale – ranging from unlikely (0-20%) to very likely (80-100%) probability. Subsequently, an FOI examination was performed. After reviewing the image reports in consensus, post-FOI diagnostic probabilities were again scored using the same scale. If no score change in the probability resulted, then the rheumatologist was asked to mark whether FOI was still helpful in the diagnostic decision making. Proportions of individuals with maximal and minimal diagnostic certainty pre-and post-test were compared using Fisher exact tests, and one-sample binomial tests for assessing the helpfulness of FOI in the absence of pre-and post-test probability score changes.

Results: Of 24 individuals screened, 21 without prior rheumatic diagnosis were included (67% female, 11 RF (+), 10 ACPA (+), with age average and symptom duration (SD) of 56 (±18) years and 14 (±15) months respectively). The final diagnosis were: early RA (n=17), other inflammatory joint disease (n=3), and non-inflammatory joint disease (n=1). Regarding diagnosis of any inflammatory arthritis, where the proportion of patients for whom the diagnostic certainty was maximal – namely, combining < 20% (lowest probability) or >80% (highest probability) of diagnostic likelihood – there was an increase from 52% (n=11/21) maximal certainty before FOI to 80% (n=17/21) maximal certainty after FOI (p=0.035). Regarding early RA, the maximal diagnostic certainty increased from 57% (n=12/21) to 71% (n=15/21) (p=0.002), respectively. The availability of ultrasound findings confirm the FOI effect. Therefore, in the event that the FOI diagnostic certainty scores did not change, pre- vs. post-test (15/21 cases, any inflammatory joint disease; 13/21 cases, early RA), the diagnosing rheumatologist indicated that FOI was still helpful in setting a final diagnosis for most cases (87% (13/15) p=0.007; 85% (11/13). p=0.022, respectively).

Conclusion: Fluorescence optical imaging significantly increased the diagnostic certainty and confidence of rheumatologists in establishing the presence and absence of inflammation in individuals suspected of inflammatory arthritis. The changes from pre-to post-test quantify the diagnostic utility of fluorescence optical imaging in probabilistic terms.

Fluorescence optical Images of normal and inflamed hand joints together with results of probability changes from minimal to maximal certainty of arthritis diagnosis, before and after FOI examination


Disclosure: Y. Kisten, None; A. Levitsky, None; H. Rezaei, None; A. Hensvold, None; P. Larsson, None; E. af Klint, None; R. van Vollenhoven, None; A. Catrina, None.

To cite this abstract in AMA style:

Kisten Y, Levitsky A, Rezaei H, Hensvold A, Larsson P, af Klint E, van Vollenhoven R, Catrina A. Fluorescence Optical Imaging in the Diagnosis of Individuals Suspected of Arthritis Development – a Probabilistic Approach [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/fluorescence-optical-imaging-in-the-diagnosis-of-individuals-suspected-of-arthritis-development-a-probabilistic-approach/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fluorescence-optical-imaging-in-the-diagnosis-of-individuals-suspected-of-arthritis-development-a-probabilistic-approach/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology